Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd. ("Intas Pharmaceuticals"), focused on the development ...
Holt-Oram syndrome is a condition that affects one out of every 100,000 people. It is rare, but it runs in Nicole Urteaga’s ...